clinicaltrials.gov 5-amino-1mq 5-Amino-1MQ 50mg — Metabolic Research

Metabolic basis for the diabetogenic action of growth hormone in the obese ( ob / ob ) mouse Endocrinology 1987 120 : 15681575

Safety Profile Across all six human trials and the extensive preclinical work, the safety picture is quite clean: No serious adverse events attributed to the compound No effect on IGF-1 No impairment of glucose tolerance or insulin sensitivity No genotoxic activity Most common side effects: mild injection site irritation, occasional headache or fatigue all transient This is genuinely one of the better-characterized peptides from a safety standpoint, largely because it actually went through a formal development process with proper clinical oversight

Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes

Figure 1 To determine whether cell death follows the pattern of superoxide levels recorded in DPI and MitoQ-treated IMR-5/75 cells, cell toxicity was measured using the CellTox Green Dye that detects modifications in membrane integrity resulting from cell death ( Figures 1A, C )